Atea Pharmaceuticals股票讨论

$Atea Pharmaceuticals (AVIR.US)$
Atea Pharmaceuticals Presents Multiple New Datasets Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024
Atea Pharmaceuticals (AVIR) presented three posters at AASLD's The Liver Meeting 2024 supporting the combination of bemnifosbuvir and ruzasvir for hepatitis C virus (HCV) treatment.
The Phase 2 lead-in cohort showed a 97% SVR12 success rate with an 8-week treatment course.
Key f...

$Atea Pharmaceuticals (AVIR.US)$
NEWS
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024

$Atea Pharmaceuticals (AVIR.US)$
NEWS
Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024
Atea Pharmaceuticals, Inc. announced the Phase 1 data presentation at ESCMID Global 2024, highlighting the favorable safety profile of bemnifosbuvir, an oral nucleotide polymerase inhibitor. The results show no cardiotoxicity in healthy participants, supporting the drug's safety profile. Atea aims to address the unmet need for COVID-19 and HCV trea...

$Atea Pharmaceuticals (AVIR.US)$  😎

$辉瑞 (PFE.US)$  Phase 3
$BioCardia (BCDA.US)$  Phase 3
$Atea Pharmaceuticals (AVIR.US)$  Phase 3
$Crinetics (CRNX.US)$  Phase 3
$Axsome Therapeutics (AXSM.US)$  Phase 3
$罗氏(ADR) (RHHBY.US)$  Phase 3
$阿卡迪亚 (ACAD.US)$  Phase 3
$Sellas Life Sciences (SLS.US)$  Phase 3
$Aquestive Therapeutics (AQST.US)$  Phase 3
$Jaguar Health (JAGX.US)$  Phase 3
$Novocure (NVCR.US)$  Phase 3
$强生 (JNJ.US)$  Phase 3

🎯 Ph 3 readouts in Q1 2024...
$辉瑞 (PFE.US)$  Phase 3
$Palatin Technologies (PTN.US)$  Phase 3
$Annovis Bio (ANVS.US)$  Phase 3
$BioCardia (BCDA.US)$  Phase 3
$Atea Pharmaceuticals (AVIR.US)$  Phase 3
$Ironwood医药 (IRWD.US)$  Phase 3
$阿里拉姆制药 (ALNY.US)$  Phase 3
$Axsome Therapeutics (AXSM.US)$  Phase 3
$ $Novocure (NVCR.US)$  Phase 3
$罗氏(ADR) (RHHBY.US)$  Phase 3
$FibroGen (FGEN.US)$  Phase 3
$阿卡迪亚 (ACAD.US)$  Phase 3
$Sellas Life Sciences (SLS.US)$...

$Atea Pharmaceuticals (AVIR.US)$  good looking chart 😎😎. Drop us some news !

$辉瑞 (PFE.US)$  Phase 3
$Regenxbio (RGNX.US)$  Phase 3
$Annovis Bio (ANVS.US)$  Phase 3
$Atea Pharmaceuticals (AVIR.US)$  Phase 3
$Ironwood医药 (IRWD.US)$  Phase 3
$阿里拉姆制药 (ALNY.US)$  Phase 3
$福泰制药 (VRTX.US)$  Phase 3
$KalVista Pharmaceuticals (KALV.US)$  Phase 3
$Axsome Therapeutics (AXSM.US)$  Phase 3
$Novocure (NVCR.US)$  Phase 3
$罗氏(ADR) (RHHBY.US)$  Phase 3
$FibroGen (FGEN.US)$  Phase 3
$Applied Therapeutics (APLT.US)$  Phase 3
$阿卡迪亚 (ACAD.US)$  Phase 3...

$Cellectar BioSciences (CLRB.US)$ Phase 2
$Regenxbio (RGNX.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals (EYPT.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$阿里拉姆制药 (ALNY.US)$ Phase 2
$Disc Medicine (IRON.US)$ Phase 2
$Atea Pharmaceuticals (AVIR.US)$ Phase 2
$Allakos (ALLK.US)$ Phase 2...